Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-02 · accession 0001179110-21-010636 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | 2021-12-02 | TBPH | GRAHAM RICHARD A | SVP, Development | A - Grant | $0.00 | +240.0K | 409.1K | +142% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-12-02 | A | A | 240,000 | $0.00 | 409,061 | D | — | — |